Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04873609 · ClinicalTrials.gov registry record · NA
Electronic Record Assimilation and Subsequent Eradication of Hepatitis C
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 1,600
- Enrollment target
NCT04873609: Completed NA study, sponsored by Stanford University.
NCT04873609 is a NA study that has completed, run by Stanford University. The registered enrollment target is 1,600 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04873609, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,600 participants
- Enrollment target
Study Summary
Given the disproportionately high risk of chronic hepatitis C virus (HCV) infection in the baby boomer cohort, population-based screening has been demonstrated cost effective. Compared to point-of-care testing, however, bulk health messages with coupled lab requisitions delivered directly to patients meeting screening criteria via patient portals could improve HCV screening at minimal cost.
Primary Outcome
completion of HCV antibody test
Interventions
- BEHAVIORAL Patient portal message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,600 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2020-04-30 |
| Phase | NA |
What the finished NCT04873609 record still lists
NCT04873609 is an interventional study that assigns participants to a tested intervention. Its 1,600 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% higher).
The record links to 0 conditions, and to 1 intervention - of which Patient portal message is the first listed.
NCT04873609 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04873609 about?
NCT04873609 is a clinical study titled "Electronic Record Assimilation and Subsequent Eradication of Hepatitis C". Given the disproportionately high risk of chronic hepatitis C virus (HCV) infection in the baby boomer cohort, population-based screening has been demonstrated cost effective. Compared to point-of-care testing, however, bulk health messages with coupled lab requisitions delivered directly to patient...
What is the current status of trial NCT04873609?
This trial is currently completed. It is a NA study. The enrollment target is 1,600 participants. The study started on 2019-05-01. Estimated completion is 2020-04-30.
What interventions are being tested in trial NCT04873609?
The interventions under investigation include: Patient portal message (BEHAVIORAL).
Who is sponsoring clinical trial NCT04873609?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04873609's enrollment target sits among peer trials
1,600 63rd of 2000 higher than 1,937 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
- NCT03511118 · 1,600 participants
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- NCT04314401 · 1,600 participants
National Cancer Institute "Cancer Moonshot Biobank"
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI